Study finds gaps in GP insulin treatment

Only 50% of GPs correctly select insulin therapy as their preferred third-line agent for patients with type 2 diabetes who are not controlled by oral hypoglycaemic drugs, according to a National Prescribing Service (NPS) survey.

Half of the 410 GPs who participated indicated they would opt for insulin as third-line agent for a patient whose glycaemia